Opko Health, Inc.
OPKAs of the close on Sep 25, 2026
Price
$1.64
Market cap
$1.22B
P/E (diluted TTM)
—
Not meaningful: the last four quarters were a loss
EPS (TTM)
−$0.09
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Opko Health, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 22, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Independent insiders buying near the same time
- 2024-01-16–2024-01-19: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2024-01-11–2024-01-18: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2024-01-05–2024-01-11: 14 event(s) across 7 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing )
- 2023-11-09–2023-11-13: 27 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-20 | PAGANELLI JOHN A · Director | Common Stock | P — Open market or private purchase | +10,000 | 1.14 | SEC filing |
| 2025-11-21 | FROST PHILLIP MD ET AL · CEO & Chairman | Common Stock | P — Open market or private purchase | +3,894 | 1.32 | SEC filing |
| 2025-11-21 | FROST PHILLIP MD ET AL · CEO & Chairman | Common Stock | P — Open market or private purchase | +89,375 | 1.33 | SEC filing |
| 2025-11-21 | FROST PHILLIP MD ET AL · CEO & Chairman | Common Stock | P — Open market or private purchase | +191,490 | 1.33 | SEC filing |
| 2025-11-21 | FROST PHILLIP MD ET AL · CEO & Chairman | Common Stock | P — Open market or private purchase | +102,371 | 1.30 | SEC filing |
| 2025-11-21 | FROST PHILLIP MD ET AL · CEO & Chairman | Common Stock | P — Open market or private purchase | +192,870 | 1.34 | SEC filing |
| 2025-11-20 | FROST PHILLIP MD ET AL · CEO & Chairman | Common Stock | P — Open market or private purchase | +161,818 | 1.34 | SEC filing |
| 2025-11-20 | FROST PHILLIP MD ET AL · CEO & Chairman | Common Stock | P — Open market or private purchase | +13,664 | 1.35 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-18 | PFENNIGER RICHARD C JR · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +60,000 | SEC filing |
| 2026-06-18 | Lachman Prem A · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-18 | MEDEL ROGER MD · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-18 | Yu Alice Lin-Tsing · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-18 | UPPALURI SUBBARAO V · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +80,000 | SEC filing |
| 2026-06-18 | PAGANELLI JOHN A · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-03-18 | UPPALURI SUBBARAO V · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2025-11-18 | FROST PHILLIP MD ET AL · CEO & Chairman | Common Stock | A — Grant, award, or other acquisition | +46,700 | SEC filing |
Showing 8 of 11 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2024-01-04 | HSIAO JANE PH D · Vice Chairman & CTO | 5% Convertible Notes due 2025 | D — Disposition to the issuer | −unknown | SEC filing |
| 2024-01-04 | FROST PHILLIP MD ET AL · CEO & Chairman | 5% Convertible Notes due 2025 | D — Disposition to the issuer | −unknown | SEC filing |
| 2023-02-10 | HSIAO JANE PH D · Vice Chairman & CTO | 5% Convertible Promissory Notes due 2023 | D — Disposition to the issuer | −unknown | SEC filing |
| 2023-02-10 | FROST PHILLIP MD ET AL · CEO & Chairman | 5% Convertible Promissory Notes due 2023 | D — Disposition to the issuer | −unknown | SEC filing |
Showing 4 of 4 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.